Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41598-018-23110-1.

Title:
Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824) | Scientific Reports
Description:
Pretomanid is a promising anti-tubercular drug currently at clinical phase III, but its mechanisms of action are currently unclear. This study aimed to: (i) reveal the metabolome of Mycobacterium smegmatis under pretomanid treatment; (ii) compare major sources of metabolite variation in bacteria treated with pretomanid treatment and other antibiotics; and (iii) to target metabolites responsible for the killing activity of pretomanid in mycobacteria. Untargeted high-resolution metabolite profiling was carried out using flow infusion electrospray ion high resolution mass spectrometry (FIE-HRMS) to identify and quantify metabolites. The identification of key metabolites was independently confirmed by gas-chromatography time-of flight mass spectrometry (GC-tofMS) in comparison to standards. Pretomanid treatments generated a unique distinctive metabolite profile when compared to ampicillin, ethambutol, ethionamide, isoniazid, kanamycin, linezolid, rifampicin and streptomycin. Metabolites which differed significantly only with pretomanid treatment were identified and mapped on to bacterial metabolic pathways. This targeted the pentose phosphate pathway with significant accumulation seen with fructose-6-phosphate, ribose-5-phosphate and glyceraldehyde-3-phosphate. These effects were linked to the accumulation of a toxic metabolite methylglyoxal. This compound showed significant antimicrobial activity (MIC 0.65 mM) against M. smegmatis.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Mobile Technology & AI

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {πŸ”}

pretomanid, article, pubmed, methylglyoxal, treatment, accumulation, google, scholar, nature, metabolite, mass, metabolites, analysis, action, smegmatis, pathway, cas, mycobacterium, bacterial, samples, data, tuberculosis, mode, metabolic, metabolism, fig, antibiotics, phosphate, glucosephosphate, central, growth, cell, metabolomics, drug, spectrometry, pentose, significant, fructosephosphate, antibiotic, metabolomic, acn, bacteria, activity, gctofms, min, content, mechanisms, mycobacteria, fiehrms, identification,

Topics {βœ’οΈ}

nature portfolio privacy policy nature communications 1 advertising 10 ΞΌl n-methyl-n-trimethylsilyltrifluoride nitroimidazo-oxazine-specific protein involved 8888/hrmet/index nature 405 nature f420-dependent glucose-6-phosphate dehydrogenase social media tb drug development reprints aba-regulated gene expression cw-cell wall synthesis author information authors promising anti-tubercular drug rational development mycobacteria-induced macrophage apoptosis clear multi-target profile full size image mid-exponential growth phase cross-validated p-values permissions thermo-scientific author correspondence original author anti-tuberculosis agent pa-824 flight mass spectrometry flight mass spectrometry tandem mass spectrometry deazaflavin dependent nitroreductase deazaflavin-dependent nitroreductase diverse nutrient conditions mycobacterium tuberculosis involved bacterial growth conditions anti-tubercular molecules access principal component analysis glucose-6-phosphate dehydrogenase intracellular accumulation glucose-6-phosphate fie-ms data untargeted metabolomics reveals accela uhplc system privacy tb therapeutic candidates published maps des-nitroimidazole derivative ps-protein synthesis esi source parameters

Questions {❓}

  • Bacterial production of methylglyoxal: a survival strategy or death by misadventure?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
         description:Pretomanid is a promising anti-tubercular drug currently at clinical phase III, but its mechanisms of action are currently unclear. This study aimed to: (i) reveal the metabolome of Mycobacterium smegmatis under pretomanid treatment; (ii) compare major sources of metabolite variation in bacteria treated with pretomanid treatment and other antibiotics; and (iii) to target metabolites responsible for the killing activity of pretomanid in mycobacteria. Untargeted high-resolution metabolite profiling was carried out using flow infusion electrospray ion high resolution mass spectrometry (FIE-HRMS) to identify and quantify metabolites. The identification of key metabolites was independently confirmed by gas-chromatography time-of flight mass spectrometry (GC-tofMS) in comparison to standards. Pretomanid treatments generated a unique distinctive metabolite profile when compared to ampicillin, ethambutol, ethionamide, isoniazid, kanamycin, linezolid, rifampicin and streptomycin. Metabolites which differed significantly only with pretomanid treatment were identified and mapped on to bacterial metabolic pathways. This targeted the pentose phosphate pathway with significant accumulation seen with fructose-6-phosphate, ribose-5-phosphate and glyceraldehyde-3-phosphate. These effects were linked to the accumulation of a toxic metabolite methylglyoxal. This compound showed significant antimicrobial activity (MIC 0.65Ҁ‰mM) against M. smegmatis.
         datePublished:2018-03-23T00:00:00Z
         dateModified:2018-03-23T00:00:00Z
         pageStart:1
         pageEnd:7
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41598-018-23110-1
         keywords:
            Antibiotics
            Metabolomics
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig6_HTML.jpg
         isPartOf:
            name:Scientific Reports
            issn:
               2045-2322
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rafael Baptista
               url:http://orcid.org/0000-0002-7155-0435
               affiliation:
                     name:Aberystwyth University, Penglais Campus
                     address:
                        name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David M. Fazakerley
               affiliation:
                     name:Aberystwyth University, Penglais Campus
                     address:
                        name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Manfred Beckmann
               affiliation:
                     name:Aberystwyth University, Penglais Campus
                     address:
                        name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Les Baillie
               affiliation:
                     name:Cardiff University, Redwood Building
                     address:
                        name:School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, Cardiff, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luis A. J. Mur
               url:http://orcid.org/0000-0002-0961-9817
               affiliation:
                     name:Aberystwyth University, Penglais Campus
                     address:
                        name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
      description:Pretomanid is a promising anti-tubercular drug currently at clinical phase III, but its mechanisms of action are currently unclear. This study aimed to: (i) reveal the metabolome of Mycobacterium smegmatis under pretomanid treatment; (ii) compare major sources of metabolite variation in bacteria treated with pretomanid treatment and other antibiotics; and (iii) to target metabolites responsible for the killing activity of pretomanid in mycobacteria. Untargeted high-resolution metabolite profiling was carried out using flow infusion electrospray ion high resolution mass spectrometry (FIE-HRMS) to identify and quantify metabolites. The identification of key metabolites was independently confirmed by gas-chromatography time-of flight mass spectrometry (GC-tofMS) in comparison to standards. Pretomanid treatments generated a unique distinctive metabolite profile when compared to ampicillin, ethambutol, ethionamide, isoniazid, kanamycin, linezolid, rifampicin and streptomycin. Metabolites which differed significantly only with pretomanid treatment were identified and mapped on to bacterial metabolic pathways. This targeted the pentose phosphate pathway with significant accumulation seen with fructose-6-phosphate, ribose-5-phosphate and glyceraldehyde-3-phosphate. These effects were linked to the accumulation of a toxic metabolite methylglyoxal. This compound showed significant antimicrobial activity (MIC 0.65Ҁ‰mM) against M. smegmatis.
      datePublished:2018-03-23T00:00:00Z
      dateModified:2018-03-23T00:00:00Z
      pageStart:1
      pageEnd:7
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41598-018-23110-1
      keywords:
         Antibiotics
         Metabolomics
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-018-23110-1/MediaObjects/41598_2018_23110_Fig6_HTML.jpg
      isPartOf:
         name:Scientific Reports
         issn:
            2045-2322
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rafael Baptista
            url:http://orcid.org/0000-0002-7155-0435
            affiliation:
                  name:Aberystwyth University, Penglais Campus
                  address:
                     name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David M. Fazakerley
            affiliation:
                  name:Aberystwyth University, Penglais Campus
                  address:
                     name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Manfred Beckmann
            affiliation:
                  name:Aberystwyth University, Penglais Campus
                  address:
                     name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Les Baillie
            affiliation:
                  name:Cardiff University, Redwood Building
                  address:
                     name:School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, Cardiff, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luis A. J. Mur
            url:http://orcid.org/0000-0002-0961-9817
            affiliation:
                  name:Aberystwyth University, Penglais Campus
                  address:
                     name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Scientific Reports
      issn:
         2045-2322
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Aberystwyth University, Penglais Campus
      address:
         name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
         type:PostalAddress
      name:Aberystwyth University, Penglais Campus
      address:
         name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
         type:PostalAddress
      name:Aberystwyth University, Penglais Campus
      address:
         name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
         type:PostalAddress
      name:Cardiff University, Redwood Building
      address:
         name:School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, Cardiff, UK
         type:PostalAddress
      name:Aberystwyth University, Penglais Campus
      address:
         name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rafael Baptista
      url:http://orcid.org/0000-0002-7155-0435
      affiliation:
            name:Aberystwyth University, Penglais Campus
            address:
               name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
               type:PostalAddress
            type:Organization
      name:David M. Fazakerley
      affiliation:
            name:Aberystwyth University, Penglais Campus
            address:
               name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
               type:PostalAddress
            type:Organization
      name:Manfred Beckmann
      affiliation:
            name:Aberystwyth University, Penglais Campus
            address:
               name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
               type:PostalAddress
            type:Organization
      name:Les Baillie
      affiliation:
            name:Cardiff University, Redwood Building
            address:
               name:School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, Cardiff, UK
               type:PostalAddress
            type:Organization
      name:Luis A. J. Mur
      url:http://orcid.org/0000-0002-0961-9817
      affiliation:
            name:Aberystwyth University, Penglais Campus
            address:
               name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
      name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
      name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK
      name:School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, Cardiff, UK
      name:Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, UK

External Links {πŸ”—}(101)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.56s.